Image de couverture de livre

Non-collapsibility and Built-in Selection Bias of Hazard Ratio in Randomized Controlled Trials

Fuente: arXiv

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Bian, Helen, Pang, Menglan, Wang, Guanbo, Lu, Zihang
Format:	Preprint
Publié:	2024
Sujets:	Methodology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Selection Bias in Hybrid Randomized Controlled Trials using External Controls: A Simulation Study
par: Chiam, Han Chang, et autres
Publié: (2025)

Using Principal Progression Rate to Quantify and Compare Disease Progression in Comparative Studies
par: Shen, Changyu, et autres
Publié: (2024)

Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial
par: Wang, Guanbo, et autres
Publié: (2022)

Impact of Non-Informative Censoring on Propensity Score Based Estimation of Marginal Hazard Ratios
par: Barros, Guilherme W. F., et autres
Publié: (2024)

COADVISE: Covariate Adjustment with Variable Selection in Randomized Controlled Trials
par: Liu, Yi, et autres
Publié: (2025)

A Non-Parametric Sensitivity Analysis for Bounding Bias in Hybrid Control Trials
par: Gordon, Alissa, et autres
Publié: (2025)

Robust Estimation of Moderated Causal Excursion Odds Ratio in Micro-Randomized Trials
par: Yu, Jiaxin, et autres
Publié: (2025)

Privacy-preserving Quantile Treatment Effect Estimation for Randomized Controlled Trials
par: Yao, Leon, et autres
Publié: (2024)

Efficient and Debiased Learning of Average Hazard Under Non-Proportional Hazards
par: Meng, Xiang, et autres
Publié: (2026)

Enhancing Statistical Validity and Power in Hybrid Controlled Trials: A Randomization Inference Approach with Conformal Selective Borrowing
par: Zhu, Ke, et autres
Publié: (2024)

Association between Sitting Time and Urinary Incontinence in the US Population: data from the National Health and Nutrition Examination Survey (NHANES) 2007 to 2018
par: Wang, Guanbo, et autres
Publié: (2024)

Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
par: Benz, Luke, et autres
Publié: (2024)

Using Instruments for Selection to Adjust for Selection Bias in Mendelian Randomization
par: Gkatzionis, Apostolos, et autres
Publié: (2022)

The Win Ratio at the Design Stage of Clinical Trials
par: Kronthaler, David, et autres
Publié: (2025)

A Practical Guide to Interpret a Randomized Controlled Trial
par: Tanboga, Ibrahim Halil
Publié: (2026)

Notes on Randomized Controlled Trials for Studying Social Media Harms
par: Felton, Chris
Publié: (2026)

Markov-Restricted Analysis of Randomized Trials with Non-Monotone Missing Binary Outcomes
par: Lee, Jaron J. R., et autres
Publié: (2021)

A Class of Computational Methods to Reduce Selection Bias when Designing Phase 3 Clinical Trials
par: Zhan, Tianyu
Publié: (2023)

Integrating Randomized Controlled Trial and External Control Data Using Balancing Weights: A Comparison of Estimands and Estimators
par: Wang, Peijin, et autres
Publié: (2025)

Efficient estimation of subgroup treatment effects using multi-source data
par: Wang, Guanbo, et autres
Publié: (2024)

The RobinCar Family: R Tools for Robust Covariate Adjustment in Randomized Clinical Trials
par: Bannick, Marlena, et autres
Publié: (2026)

Continuous-time structural failure time model for intermittent treatment
par: Wang, Guanbo, et autres
Publié: (2024)

On the Graphical Rules for Recovering the Average Treatment Effect Under Selection Bias
par: Zhang, Yichi, et autres
Publié: (2025)

CausalMetaR: An R package for performing causally interpretable meta-analyses
par: Wang, Guanbo, et autres
Publié: (2024)

Covariate Ordered Systematic Sampling as an Improvement to Randomized Controlled Trials
par: Jobson, Deddy, et autres
Publié: (2024)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
par: Qiu, Sky, et autres
Publié: (2026)

Taming Variability: Randomized and Bootstrapped Conformal Risk Control for LLMs
par: Pang, Lingyou, et autres
Publié: (2025)

Causal Survival Analysis in Platform Trials with Non-Concurrent Controls
par: D'Alessandro, Antonio, et autres
Publié: (2026)

Complier General Causal Effect in Randomized Controlled Trials with One-Sided Noncompliance
par: Tang, Yin, et autres
Publié: (2025)

Efficient Randomized Experiments Using Foundation Models
par: De Bartolomeis, Piersilvio, et autres
Publié: (2025)

Improving the Efficiency of Subgroup Analysis in Randomized Controlled Trials with TMLE
par: Qiu, Sky, et autres
Publié: (2026)

Synthetic Heterogeneous-Effects LASSO: A Fixed-effects Estimation Approach for High-dimensional Mixed-effects Models
par: Ye, Shangyuan, et autres
Publié: (2026)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
par: Wang, Hao, et autres
Publié: (2025)

Harmonized Estimation of Subgroup-Specific Treatment Effects in Randomized Trials: The Use of External Control Data
par: Schwartz, Daniel, et autres
Publié: (2023)

Improving Power in Randomized Controlled Trials with Time-to-Event Endpoints: A Risk-Free Approach
par: Zhou, Junyi, et autres
Publié: (2026)

Incorporating Participants' Welfare into Sequential Multiple Assignment Randomized Trials
par: Wang, Xinru, et autres
Publié: (2022)

Adaptive Selection of the Optimal Strategy to Improve Precision and Power in Randomized Trials
par: Balzer, Laura B., et autres
Publié: (2022)

Comment on "Average Hazard as Harmonic Mean" by Chiba
par: Uno, Hajime, et autres
Publié: (2025)

Causal Inference in Randomized Trials with Partial Clustering
par: Nugent, Joshua, et autres
Publié: (2024)

Interim Analysis in Sequential Multiple Assignment Randomized Trials for Survival Outcomes
par: Wang, Zi, et autres
Publié: (2025)